Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of GBP 2.11 billion. The enterprise value is 2.19 billion.

Market Cap	2.11B
Enterprise Value	2.19B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Apr 26, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	74.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.04, with an EV/FCF ratio of 42.48.

EV / Earnings	-7.83
EV / Sales	8.36
EV / EBITDA	25.04
EV / EBIT	38.50
EV / FCF	42.48

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.16.

Current Ratio	2.91
Quick Ratio	2.26
Debt / Equity	0.16
Debt / EBITDA	1.73
Debt / FCF	2.92
Interest Coverage	14.57

Financial Efficiency

Return on equity (ROE) is -24.89% and return on invested capital (ROIC) is 2.77%.

Return on Equity (ROE)	-24.89%
Return on Assets (ROA)	2.54%
Return on Capital (ROIC)	2.77%
Revenue Per Employee	235,388
Profits Per Employee	-251,942
Employee Count	1,123
Asset Turnover	0.19
Inventory Turnover	3.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +80.22% in the last 52 weeks. The beta is 1.80, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	+80.22%
50-Day Moving Average	218.62
200-Day Moving Average	210.78
Relative Strength Index (RSI)	47.61
Average Volume (20 Days)	1,575

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of GBP 261.52 million and -279.91 million in losses. Loss per share was -2.07.

Revenue	261.52M
Gross Profit	152.13M
Operating Income	56.79M
Pretax Income	-267.70M
Net Income	-279.91M
EBITDA	84.97M
EBIT	56.79M
Loss Per Share	-2.07

Full Income Statement

Balance Sheet

The company has 68.05 million in cash and 150.80 million in debt, giving a net cash position of -82.76 million.

Cash & Cash Equivalents	68.05M
Total Debt	150.80M
Net Cash	-82.76M
Net Cash Per Share	n/a
Equity (Book Value)	966.62M
Book Value Per Share	7.14
Working Capital	101.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 59.66 million and capital expenditures -8.09 million, giving a free cash flow of 51.57 million.

Operating Cash Flow	59.66M
Capital Expenditures	-8.09M
Free Cash Flow	51.57M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.17%, with operating and profit margins of 21.72% and -107.03%.

Gross Margin	58.17%
Operating Margin	21.72%
Pretax Margin	-102.36%
Profit Margin	-107.03%
EBITDA Margin	32.49%
EBIT Margin	21.72%
FCF Margin	19.72%

Dividends & Yields

Vitrolife AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	11.07%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	-13.28%
FCF Yield	2.45%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 4.4.

Altman Z-Score	4.4
Piotroski F-Score	n/a